Exposure to tiny doses of hormone-disrupting chemicals is responsible for at least $340 billion (310 billion euros) in health-related costs each year in the United States, according to a report published Tuesday. Neurological damage and behavioural problems, including attention-deficit/hyperactivity disorder (ADHD), autism and loss of IQ, accounted for at least four-fifths of these impacts, researchers said in The Lancet Diabetes & Endocrinology, a medical journal. "Our research adds to the growing evidence on the tremendous economic as well as human health costs of endocrine-disrupting chemicals," said lead investigator Leonardo Trasande, an associate professor at NYU Langone in New York City.
Go to Source